NeueHealth, Inc. (NYSE:NEUE - Get Free Report) CAO Jeffrey J. Scherman sold 1,368 shares of the business's stock in a transaction on Monday, January 6th. The shares were sold at an average price of $7.33, for a total transaction of $10,027.44. Following the sale, the chief accounting officer now directly owns 5,942 shares of the company's stock, valued at $43,554.86. This represents a 18.71 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink.
NeueHealth Stock Up 0.7 %
NYSE:NEUE traded up $0.05 during midday trading on Wednesday, hitting $7.45. The stock had a trading volume of 38,124 shares, compared to its average volume of 70,685. The company has a market capitalization of $61.72 million, a price-to-earnings ratio of -0.15 and a beta of 0.57. NeueHealth, Inc. has a one year low of $3.79 and a one year high of $16.59. The stock has a 50-day moving average of $5.47 and a 200 day moving average of $5.38.
Institutional Inflows and Outflows
Institutional investors have recently added to or reduced their stakes in the business. Deer Management Co. LLC purchased a new stake in shares of NeueHealth in the 2nd quarter worth approximately $5,436,000. NEA Management Company LLC bought a new position in NeueHealth in the second quarter worth approximately $14,834,000. Renaissance Technologies LLC purchased a new stake in NeueHealth during the second quarter worth $312,000. Finally, Partners Group Holding AG bought a new stake in NeueHealth during the 3rd quarter valued at $463,000. Hedge funds and other institutional investors own 63.88% of the company's stock.
Analysts Set New Price Targets
Separately, Royal Bank of Canada decreased their price objective on shares of NeueHealth from $8.00 to $7.00 and set a "sector perform" rating for the company in a report on Monday, December 9th.
Get Our Latest Research Report on NeueHealth
NeueHealth Company Profile
(
Get Free Report)
NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider NeueHealth, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NeueHealth wasn't on the list.
While NeueHealth currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.